North American multicenter experience with the On-X® prosthetic heart valve

Journal of Heart Valve Disease

Volumn 15, Issue 1, 2006, Pages 73-79

  McNicholas, Kathleen W ^a,j   Ivey, Tom D ^b   Metras, Jacques ^c   Szentpetery, Szabolcs ^d   Marra, Steven W ^e   Masters, Roy G ^f   Dilling, Emery W ^g   Slaughter, Mark S ^h   Mack, Michael J ⁱ  

^a CHRISTIANA CARE HEALTH SYSTEM   (United States)

^b Ohio Heart Institute   (United States)

^c LAVAL UNIVERSITY   (Canada)

^d SENTARA NORFOLK GENERAL HOSPITAL   (United States)

^e Department of Anesthesiology   (United States)

^f UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^g St David's Hospital   (United States)

^h ADVOCATE CHRIST MEDICAL CENTER   (United States)

ⁱ Medical City Hospital   (United States)

^j Cardio Vascular Surgical Associates   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LACTATE DEHYDROGENASE; WARFARIN;

ADULT; AGED; ANTICOAGULATION; AORTA VALVE DISEASE; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART VALVE PROSTHESIS; HEMODYNAMICS; HEMOLYSIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; KAPLAN MEIER METHOD; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE DISEASE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; MULTICENTER STUDY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RHEUMATIC HEART DISEASE; SAFETY; SINUS RHYTHM; THROMBOEMBOLISM; THROMBOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; AORTIC VALVE; BIOLOGICAL MARKERS; EQUIPMENT SAFETY; FEMALE; FOLLOW-UP STUDIES; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; MITRAL VALVE; NORTH AMERICA; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; TREATMENT OUTCOME;

EID: 31844455415     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Laczkovics A, Heidt M, Oelert H, et al. Early clinical experience with the On-X® prosthetic heart valve. J Heart Valve Dis 2001;10:94-99
2. Moidl R, Simon P, Wolner E, et al. The On-X prosthetic heart valve at five years. Ann Thorac Surg 2002;74:S1312-S1317
3. Birnbaum D, Laczkovics A, Heidt M, et al. Examination of the hemolytic potential with the On-X prosthetic heart valve. J Heart Valve Dis 2000;9:142-145
4. Chambers J, Ely JL, et al. Early postoperative echocardiographic hemodynamic performance of the On-X prosthetic heart valve: A multicenter study. J Heart Valve Dis 1998;7:569-573
5. Gohlke-Barwolf C, Acar J, Burkhardt D, et al. Guidelines for prevention of thromboembolic events in valvular heart disease. J Heart Valve Dis 1993;2:398-410
6. Edmunds LH, Clark RE, Cohn LH, et al. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg 1996;62:932-935
7. ACC/AHA Pocket Guidelines. Management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association task force on practice guidelines. July 2000
8. Salem DN, Stein PD, Al-Ahmad A, et al. Anti-thrombotic therapy in valvular heart disease - native and prosthetic. Chest 2004;126:457S-482S
9. Akins C. Results with mechanical cardiac valvular prostheses. Ann Thorac Surg 1995;60:1836-1844
10. Koertke H, Koerfer R. International normalized ratio self-management after mechanical heart valve replacement: Is an early start advantageous? Ann Thorac Surg 2001;72:44-48
11. Williams MA, Van Riet S. The On-X heart valve - mid-term results in a poorly anticoagulated population. J Heart Valve Dis 2006;15: in press
12. Colli A, Pare C, Rufilanchas JJ, et al. The On-X prosthetic heart valve: Early results of a European trial. 3rd Biennial Meeting, Society for Heart Valve Disease, Vancouver, BC, Canada, June 17-20, 2005
13. Skoularigis J, Essop MR, Skudicky D, et al. Frequency and severity of intravascular hemolysis after left-sided cardiac valve replacement with Medtronic Hall and St. Jude Medical prostheses, and influence of prosthetic type, position, size and number. Am J Cardiol 1993;71:587-591
14. Mecozzi G, Milano AD, DeCarlo M, et al. Intravascular hemolysis in patients with new-generation prosthetic heart valves: A prospective study. J Thorac Cardiovasc Surg 2002;123:550-556
15. Roedler SM, Moritz A, Schreiner W, et al. Five-year follow-up after heart valve replacement with the CarboMedics bileaflet prosthesis. Ann Thorac Surg 1997;63:1018-1025